Phase III results of the IL-17A antagonist ixekizumab for radiographic axial spondyloarthritis Nov. 8, 2018
DS-003 vaginal microbicide tablet achieves protective levels after administration to healthy women Nov. 8, 2018
Discovery and optimization of Aurora B-selective SYK inhibitors as topical agents for skin diseases Nov. 8, 2018
Preliminary results of phase I study of MK-1454/pembrolizumab for advanced solid tumors or lymphomas Nov. 8, 2018
PLB-002, a SUMO mimetic polypeptide, shows inhibition of tau toxicity and motor/memory impairment Nov. 8, 2018
MicroRNA 31 levels predict response of patients with colon cancer to adjuvant cetuximab therapy Nov. 8, 2018
RSS